PAMIDRONATE DISODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pamidronate Disodium, and what generic alternatives are available?
Pamidronate Disodium is a drug marketed by Aesgen, Am Regent, Areva Pharms, Dr Reddys, Fresenius Kabi Usa, Hikma, Hospira, Mn Pharms, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharma Global, and Teva Pharms Usa. and is included in fourteen NDAs.
The generic ingredient in PAMIDRONATE DISODIUM is pamidronate disodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pamidronate Disodium
A generic version of PAMIDRONATE DISODIUM was approved as pamidronate disodium by HIKMA on April 30th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PAMIDRONATE DISODIUM?
- What are the global sales for PAMIDRONATE DISODIUM?
- What is Average Wholesale Price for PAMIDRONATE DISODIUM?
Summary for PAMIDRONATE DISODIUM
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 8 |
| Patent Applications: | 3,690 |
| DailyMed Link: | PAMIDRONATE DISODIUM at DailyMed |
Recent Clinical Trials for PAMIDRONATE DISODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Peking Union Medical College Hospital | Phase 1 |
| The Hospital for Sick Children | N/A |
| National Cancer Institute (NCI) | Phase 1 |
Pharmacology for PAMIDRONATE DISODIUM
| Drug Class | Bisphosphonate |
US Patents and Regulatory Information for PAMIDRONATE DISODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Global | PAMIDRONATE DISODIUM | pamidronate disodium | INJECTABLE;INJECTION | 077703-001 | Dec 24, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharma Global | PAMIDRONATE DISODIUM | pamidronate disodium | INJECTABLE;INJECTION | 077703-002 | Dec 24, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aesgen | PAMIDRONATE DISODIUM | pamidronate disodium | INJECTABLE;INJECTION | 075594-001 | May 6, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | PAMIDRONATE DISODIUM | pamidronate disodium | INJECTABLE;INJECTION | 021113-002 | Mar 4, 2002 | AP1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Labs Ltd | PAMIDRONATE DISODIUM | pamidronate disodium | INJECTABLE;INJECTION | 078520-001 | Oct 31, 2008 | AP2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
